News & Events

260 patients enrolled in the SHIELD Phase 2 study, first headline results expected by the end of the year 2…

The BIO International Convention brings together the leaders in the biotechnology and pharmaceutical industries. A “can’t miss” Event! We look…

ChinaBio is the most important annual biopharma partnering event where you can join 1,400+ pharma, biotech and finance leaders from…

ECCMID, the world’s premier Clinical Microbiology & Infectious Diseases event, brings together experts from many fields to present their latest…

This year’s event in Vienna will bring together the “who’s who” from the biotech, pharma and finance segments to allow…

We are thrilled to announce we are part of the ten finalists for the Lyfebulb Helsinn 2019 Innovation Summit in…

The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and public…

Understanding and taming the costs of diseases associated to the gut microbiota disruption has always been a priority for Da…

The 4th Annual North America Microbiome Congress in Washington DC, by Kisaco Research, has become a trusted learning and networking…

Da Volterra pleased to attend the ‘3rd Microbiome Movement – Drug Development Europe 2019’ conference taking place in Paris, on…